Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing

This response-to-comments document (A59020) records a title revision for LCD L39044 and the timeline of the public comment and notice periods but does not provide clinical coverage criteria. The DL39044 comment period was 5/20/2021–7/3/2021; the notice began 3/3/2022 and the LCD became effective 4/17/2022. For specific coverage, coding, and documentation rules, refer to the full LCD L39044.

"This document is a response to comments and does not itself establish clinical coverage criteria; consult LCD L39044 (MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identificatio..."

Sign up to see full coverage criteria, indications, and limitations.